“Formulation and Optimization of Liquisolid Tablet for Improving the Dissolution Profile of Rivaroxaban by Using DoE Approachand Antithrombic Activity”. Journal of Carcinogenesis, vol. 24, no. 3s, Oct. 2025, pp. 812-30, https://doi.org/10.64149/J.Carcinog.24.3s.812-830.